At a glance
Our 2021 Financial Highlights
Strong overall revenue growth driven by Consumer Healthcare, underpinned by continued market penetration via e-commerce activity, which now represents around 25% of Group sales
169.6 £m See-through Revenue*
42.2 £m Underlying Profit Before Tax
6.39p Underlying Basic EPS
163.2 £m Statutory Revenue
18.2 £m Reported Profit Before Tax
*Non-IFRS alternative performance measures. See-through revenue includes all sales from Nizoral as if they had been invoiced by Alliance as principal. For statutory accounting purposes the product margin on Nizoral sales made on an agency basis is included within Revenue, in line with IFRS 15.
Results centreBuilt for modern business
An inter-connected network of people and brands
A global range of products delivering outstanding value. Many partners working together; one team, achieving more.
Downloads & useful links
REGULATORY NEWS
- 01 FEB 23 Appointment of NED and SID
- 30 JAN 23 Notification of Major Holdings
- 17 JAN 23 Full Year Trading Update